IL6 and metabolic dysfunction-associated steatotic liver disease: NAFLD may potentially contribute to the development of cardiovascular complications as demonstrated by the increased production of pro-inflammatory cytokines such as C-reactive protein, interleukin-6, tumor necrosis factor – alpha and prothrombotic factors [17-18].